References
- Hui KPY, Cheung MC, Perera RAPM, et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020;8(7):687–695. doi:https://doi.org/10.1016/S2213-2600(20)30193-4.
- Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:https://doi.org/10.1080/09273948.2020.1738501.
- Arora R, Goel R, Kumar S, et al. Evaluation of SARS-CoV-2 in tears of patients with moderate to severe COVID-19. Ophthalmology. 2020 Aug 31:S0161-6420(20)30847-2. doi:https://doi.org/10.1016/j.ophtha.2020.08.029.
- Karimi S, Arabi A, Shahraki T, Safi S. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019. Eye. 2020;34(7):1220–1223. doi:https://doi.org/10.1038/s41433-020-0965-2.
- Marra AR, Edmond MB, Popescu SV, Perencevich EN. Examining the need for eye protection for coronavirus disease 2019 (COVID-19) prevention in the community. Infect Control Hosp Epidemiol. 2020 Jun 24:1–2. doi:https://doi.org/10.1017/ice.2020.314.
- Guo ZD, Wang ZY, Zhang SF, et al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis. 2020 Jul;26(7):1583–1591. doi:https://doi.org/10.3201/eid2607.200885.
- Centers for Disease Control and Prevention Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings. March 19, 2020. https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Finfection-control.html. Published November 2020. Accessed November 20, 2020.
- Arabi YM, Phua J, Koh Y, et al. Structure, organization, and delivery of critical care in Asian ICUs. Crit Care Med. 2016;44(10):e940–e948.doi:https://doi.org/10.1097/CCM.0000000000001854.
- WHO Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19): interim guidance. https://apps.who.int/iris/bitstream/handle/10665/331215/WHO-2019-nCov-IPCPPE_use-2020.1-eng.pdf. Published February 2020. Accessed November 20, 2020.
- Hanege FM, Kocoglu E, Kalcioglu MT, et al. SARS-CoV-2 presence in the saliva, tears, and cerumen of COVID-19 patients [published online ahead of print, 2020 Oct 23]. Laryngoscope. 2020. doi:https://doi.org/10.1002/lary.29218.
- Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi:https://doi.org/10.1001/jamaophthalmol.2020.1291.
- Clinical management protocol: COVID-19. https://www.mohfw.gov.in/pdf/ClinicalManagementProtocolforCOVID19dated27062020.pdf. Published June 2020. Accessed November 20, 2020.
- SOP for detection of 2019 novel coronavirus (2019-nCoV) in suspected human cases by rRT-PCR: screening assay ICMR NIV Pune. https://www.icmr.gov.in/pdf/covid/labs/1_SOP_for_First_Line_Screening_Assay_for_2019_nCoV.pdf. Published April 2020. Accessed November 20, 2020.
- SOP for detection of 2019 novel coronavirus (2019-nCoV) in suspected human cases by rRT-PCR: confirmation assay ICMR NIV Pune. https://www.icmr.gov.in/pdf/covid/labs/2_SOP_for_Confirmatory_Assay_for_2019_nCoV.pdf. Published April 2020. Accessed November 20, 2020.
- Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8.doi:https://doi.org/10.1016/j.cell.2020.02.052.
- Leonardi A, Rosani U, Brun P. Ocular surface expression of SARS-CoV-2 receptors. Ocul Immunol Inflamm. 2020 Jul 3;28(5):735–738. doi:https://doi.org/10.1080/09273948.2020.1772314.
- Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589–594. doi:https://doi.org/10.1002/jmv.25725.
- Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-CoV-2 in COVID-19 patients. Ophthalmology. 2020;127(7):982–983. doi:https://doi.org/10.1016/j.ophtha.2020.04.028.
- Sun C, Wang Y, Liu G, Liu Z. Role of the eye in transmitting human coronavirus: what we know and what we do not know. Front Public Health. 2020;8:155. doi:https://doi.org/10.3389/fpubh.2020.00155.
- Kumar K, Prakash AA, Gangasagara SB, et al. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients. Indian J Ophthalmol. 2020;68(6):1015–1017. doi:https://doi.org/10.4103/ijo.IJO_1287_20.
- Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973–1987.doi:https://doi.org/10.1016/S0140-6736(20)31142-9.
- Ho D, Low R, Tong L, Gupta V, Veeraraghavan A, Agrawal R. COVID-19 and the ocular surface: a review of transmission and manifestations. Ocul Immunol Inflamm. 2020;28(5):726–734. doi:https://doi.org/10.1080/09273948.2020.1772313.
- Richterman A, Meyerowitz EA, Cevik M. Hospital-acquired SARS-CoV-2 infection: lessons for public health [published online ahead of print, 2020 Nov 13]. JAMA. 2020. doi:https://doi.org/10.1001/jama.2020.21399.
- Bullard J, Dust K, Funk D, et al. Predicting infectious SARS-CoV-2 from diagnostic samples [published online ahead of print, 2020 May 22]. Clin Infect Dis. 2020;ciaa638. doi:https://doi.org/10.1093/cid/ciaa638.
- Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6):748–751. doi:https://doi.org/10.1136/bjophthalmol-2020-316304.
- Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020;173(3):242–243. doi:https://doi.org/10.7326/M20-1176.
- Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19 [published online ahead of print, 2020 Apr 26]. Acta Ophthalmol. 2020. doi:https://doi.org/10.1111/aos.14445.
- Scalinci SZ, Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. 2020;20:e00774. doi:https://doi.org/10.1016/j.idcr.2020.e00774.
- Khavandi S, Tabibzadeh E, Naderan M, Shoar S. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic. Cont Lens Anterior Eye. 2020 Jun;43(3):211–212. doi:https://doi.org/10.1016/j.clae.2020.04.010.
- Han H, Luo Q, Mo F, Long L, Zheng W. SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients [published correction appears in Lancet Infect Dis. 2020 May;20(5):e79]. Lancet Infect Dis. 2020;20(6):655–656. doi:https://doi.org/10.1016/S1473-3099(20)30174-2.
- Abdul-Kadir MA, Lim LT. Human coronaviruses: ophthalmic manifestations. BMJ Open Ophthalmol. 2020 Nov 2;5(1):e000630. doi:https://doi.org/10.1136/bmjophth-2020-000630.
- Boz AAE, Atum M, Çakır B, Karabay O, Çelik E, Alagöz G. Outcomes of the ophthalmic examinations in patients infected by SARS-CoV-2. Ocul Immunol Inflamm. 2020 Nov;23:1–4. doi:https://doi.org/10.1080/09273948.2020.1844904.
- Sun L, Hymowitz M, Pomeranz HD. Eye protection for patients with COVID-19 undergoing prolonged prone-position ventilation [published online ahead of print, 2020 Nov 19]. JAMA Ophthalmol. 2020. doi:https://doi.org/10.1001/jamaophthalmol.2020.4988.
- Cavalleri M, Brambati M, Starace V, et al. Ocular features and associated systemic findings in SARS-CoV-2 Infection. Ocul Immunol Inflamm. 2020 Aug 17;28(6):916–921. doi:https://doi.org/10.1080/09273948.2020.1781198.